Tessera Therapeutics names former Merck executive as new CEO
Go back to Tessera Therapeutics names former Merck executive as new CEO| Merck & Co. (NYSE: MRK) | Delayed: 129.79 -0.57 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.36 | 52 Week High | $65.46 | |||
| Open | $128.20 | 52 Week Low | $47.97 | |||
| Day High | $130.21 | P/E | 88.29 | |||
| Day Low | $127.25 | EPS | $1.47 | |||
| Volume | 7,833,118 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 738.34 +42.92 (6.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $695.42 | 52 Week High | $592.36 | |||
| Open | $701.90 | 52 Week Low | $325.35 | |||
| Day High | $740.00 | P/E | 193.79 | |||
| Day Low | $694.98 | EPS | $3.81 | |||
| Volume | 1,460,962 | |||||
